PGA1-induced apoptosis involves specific activation of H-Ras and N-Ras in cellular endomembranes by Anta, B. et al.
OPEN
PGA1-induced apoptosis involves specific activation of
H-Ras and N-Ras in cellular endomembranes
B Anta1,7, A Pérez-Rodríguez1,7, J Castro1,7, CA García- Domínguez1, S Ibiza2,8, N Martínez1, LM Durá1, S Hernández1, T Gragera1,
D Peña-Jiménez1, M Yunta1, N Zarich1, P Crespo3, JM Serrador4, E Santos5, A Muñoz6, JL Oliva*,1,9 and JM Rojas-Cabañeros*,1,9
The cyclopentenone prostaglandin A1 (PGA1) is an inducer of cell death in cancer cells. However, the mechanism that initiates this
cytotoxic response remains elusive. Here we report that PGA1 triggers apoptosis by a process that entails the specific activation of
H- and N-Ras isoforms, leading to caspase activation. Cells without H- and N-Ras did not undergo apoptosis upon PGA1 treatment;
in these cells, the cellular demise was rescued by overexpression of either H-Ras or N-Ras. Consistently, the mutant H-Ras-C118S,
defective for binding PGA1, did not produce cell death. Molecular analysis revealed a key role for the RAF-MEK-ERK signaling
pathway in the apoptotic process through the induction of calpain activity and caspase-12 cleavage. We propose that PGA1 evokes
a specific physiological cell death program, through H- and N-Ras, but not K-Ras, activation at endomembranes. Our results
highlight a novel mechanism that may be of potential interest for tumor treatment.
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The mammalian genome contains three ras genes that
encode the 21-kDa proteins H-Ras, N-Ras, and K-Ras with
their two isoforms, K-Ras4A and K-Ras4B, which are
generated from two alternative fourth exons. Ras proteins
are small GTPases that act as molecular switches connecting
a wide spectrum of extracellular signals from cell-surface
receptors to intracellular pathways to control cell proliferation,
differentiation, senescence, and death.1 Ras proteins are
activated by guanine nucleotide-exchange factors, which
promote the exchange of guanosine diphosphate (GDP) for
guanosine triphosphate (GTP), resulting in a conformational
change of the tertiary structure of Ras and exposing its effector
loop to interacting partners. The intrinsic GTPase activity of
Ras proteins stimulated by GTPase-activating proteins
restores the GDP-bound state and terminates Ras signaling.
Active GTP-bound Ras interacts with effector proteins
that modulate different signaling pathways to generate specific
biological outcomes. As Ras proteins are ubiquitously
expressed (except K-Ras4A)2 and share a high degree of
sequence homology and a large number of molecular
activators, it was long assumed that their role was redundant.
However, functional redundancy is not complete, as demon-
strated by embryonic lethality in K-Ras knockouts3,4 and the
demonstration that the three Ras proteins have specific roles
according to Ras isoform-dependent subcellular compart-
mentalization.5 This observation implies that biochemical and
biophysical aspects of specific subcellular sites determine
both the Ras isoform and the set of effectors that could be
recruited, thus generating different molecular and biological
outputs.6 Cyclopentenone prostaglandins (CyPGs) are eico-
sanoids with a varied spectrum of biological activity, including
anti-inflammatory and antitumor effects, induction of oxidative
stress, modulation of heat-shock response (HSP), and anti-
viral activity.7,8 They are thought to originate from the free
radical-induced peroxidation of arachidonic acid (isoprostane
pathway)9 and the dehydration of prostaglandins.10 CyPG
contain an α,β-unsaturated carbonyl group in the cyclopen-
tane ring that favors the formation of Michael adducts with
sulfhydryl groups of proteins.11 Thismechanism is responsible
for many of the biological properties of these compounds.
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However, the variety of cellular responses to CyPG appears to
be cell type-specific and concentration-dependent; indeed,
cytoprotective and cytotoxic responses have been associated
with low and high concentrations of CyPG, respectively.12,13
In this regard, we reported that H-Ras is a target for the
addition of a typical CyPG, the 15-deoxy-12,14-prostaglandin
J2 (15d-PGJ2), and that this effect is associated with specific
activation of H-Ras-dependent pathways and increased
proliferation and inhibition of apoptosis in NIH3T3 fibro-
blasts14 and MCA3D keratinocytes.15 Nevertheless, members
of the prostaglandin A and J series act as potent inhibitors of
some human tumors both in vitro and in vivo, by inducing cell
cycle arrest and apoptosis.7,10 In endothelial cells, activation
of peroxisome proliferator-activated receptor (PPAR) recep-
tors by 15d-PGJ2 induces nuclear localization of receptors
and caspase-mediated apoptosis,16 and both 15d-PGJ2 and
cyclopentenone prostaglandin A1 (PGA1) induce apoptosis in
AGS cells by a PPAR-independent mechanism.17 Although
the role of CyPG as inducers of apoptosis is well documented,
the relationship between Ras activation by CyPG and
triggering of apoptosis, or proliferation, is not fully understood.
We have explored the molecular mechanisms underlying
PGA1-induced apoptosis. We found that PGA1 induces
apoptosis in mouse fibroblasts by specific binding to and
activation of H- and N-Ras at endomembranes, and that this
process requires activation of extracellular signal-regulated
kinases (ERKs). A detailed analysis revealed that the
mechanism of cell death induced by PGA1 requires ERK-
mediated activation of calpain, an endoplasmic reticulum (ER)
protease, and leads to a caspase-dependent apoptosis.
Finally, we present evidence that the mechanism of apoptosis
is shared by human cancer cells.
Results
PGA1 induces apoptosis in MEFs. The CyPGs display
potent antiproliferative activity in various cellular models.
These compounds induce cell cycle arrest or apoptosis
depending on the cell type and treatment conditions.18,19
Synchronously starved NIH3T3 cells were incubated in the
presence of PGA1 to assess antiproliferative activity (accord-
ing to the scheme shown in Supplementary Figure S1A). Cell
number decreased sharply: no viable cells remained after
48 h of treatment, even in the presence of strong mitogenic
signals such as fibroblast growth factor (FGF) (Figure 1a).
Flow cytometry analysis of propidium iodide-stained cells
revealed that ~ 75% of PGA1-treated cells showed an
increase in cells with hypodiploid DNA content after
24 h (Supplementary Figure S1B). In addition, DAPI (4′,
6-diamidino-2-phenylindole) staining also revealed apoptotic
nuclear morphology after 24 h (Supplementary Figure S1C).
Caspase cleavage was examined to verify that the effects of
PGA1 reflected apoptosis. Western blotting using antibodies
that detect both procaspase and activated cleaved forms
revealed the presence of cleaved caspase-12, -9, and -3 in
cell lysates from PGA1-treated cells, as well as cleaved
poly(ADP-ribose) polymerase (PARP), a typical target for
activated caspase-3 (Figure 1b). Moreover, both annexin
V-binding analysis (Figure 1c) and DNA laddering (Supple-
mentary Figure S1D) indicated that this cell death was due to
an apoptotic process. In agreement with these data, both
caspase-3 activation and the increase in annexin V-positive
cells were completely abolished by the pancaspase inhibitor
Z-Asp-CH2-DCB (Figure 1d). Taken together, these results
demonstrate that treatment of mouse fibroblast cells with
PGA1 leads to apoptosis through activation of a caspase-
dependent pathway.
PGA1-induced apoptosis requires expression of H- and
N-Ras. PGA1-induced apoptosis has been reported in
several cellular models, including cancer cells.10 However,
the precise molecular mechanism by which PGA1 elicits cell
elimination remains unclear. We have previously reported
that PGA1 binds to and activates H- Ras, N-Ras, and K-Ras
to a similar extent.20 As Ras proteins promote activation
of the effector cascades that trigger apoptosis, we used
a knockout approach to evaluate the potential role of these
proteins in mediating PGA1-dependent apoptosis (Supple-
mentary Figure S2A). Analysis of relevant apoptosis markers
upon PGA1 incubation in mouse embryonic fibroblasts
(MEFs) for H-Ras− /− or N-Ras− /− did not reveal differences
in caspase activation or in PARP proteolysis compared
with wt MEFs. Interestingly, in H-Ras− /−/N-Ras− /− double-
knockout MEFs, PGA1 failed to induce caspase activation
and apoptosis (Figure 2a). Ectopic restitution of H-Ras or
N-Ras expression in double-knockout cells caused cell death
increase, activation of PARP, and caspase-3 by PGA1
(Figure 2b and Supplementary Figure S2B). Given that
PGA1-induced apoptosis requires expression of H-Ras or
N-Ras, we reasoned that overexpression of these isoforms
could synergize with the PGA1 effects. Indeed, PGA1-induced
dose-dependent increases in cleaved caspase-3 levels were
much greater in NIH3T3 cell lines stably overexpressing
ectopic AU5-H-Ras-wt or AU5-N-Ras-wt than in control cell
lines (Figure 2c, upper panel). In agreement with these data,
treatment of Ras-overexpressing fibroblasts with PGA1
markedly increased the population of annexin V-positive cells
(Figure 2c, lower panel). Moreover, ectopic expression of a
dominant-negative mutant of H-Ras (H-Ras-N17) reduced
caspase-3 activation levels upon stimulation with PGA1
(Figure 2d). Taken together, these results show that signaling
by H-Ras and N-Ras, but not K-Ras, are required to promote
PGA1-induced apoptosis.
Ras-Cys118 residue is required for PGA1-induced apop-
tosis. Our previous studies showed that PGA1 binds
preferably to Cys118 in all three Ras proteins, and Cys184
and Cys181 in H-Ras. However, rather than Cys184 or
Cys181, PGA1 activates H-Ras by binding to Cys118.
20 As
Cys181 is shared by N-Ras and H-Ras, whereas Cys184 is
unique to H-Ras, we speculated that Ras-Cys118 was the
main target for PGA1 in mediating apoptosis. To determine
the relative contribution of Cys118, double-knockout
MEFs were transfected with H-Ras-wt, H-Ras-C118S, or
H-Ras-C184S. As shown in Figure 3a and Supplementary
Figure S2B, expression of H-Ras-wt or H-Ras-C184S
induced cell death increase and caspase-3 activation in
response to PGA1, whereas expression of H-Ras-C118S
did not. Furthermore, analysis of transfected PGA1-stimulated
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MEFs showed that the C118S mutant did not increase
the annexin V-positive cell population (Figure 3b). These data
provide strong evidence that Cys118 of H- and N-Ras is
necessary for PGA1-induced apoptosis.
PGA1 induces Ras activation in endomembranes. To
examine whether activation of Ras by PGA1 could be
affected by intracellular localization, we measured the Ras-
GTP levels induced by PGA1 in HeLa cells transiently
Figure 1 PGA1 promotes apoptosis in mouse fibroblasts. (a) Serum-starved NIH3T3 cells were treated with 30 μM PGA1 (Supplementary Figure S1A), 50 ng/ml FGF, or
DMSO every 24 h. (Upper panel) Cells were collected at 24, 48, or 72 h and scored by cell counting; data are presented as mean± S.D. (n= 3). (Lower panel) Cell morphology
was recorded by phase-contrast micrograph 24 h after treatment. (b) Serum-starved cultures of wt MEFs were stimulated with 30 μM PGA1 or DMSO and harvested 3 h after
treatment. Lysates prepared from cells were analyzed by western blotting for procleaved and cleaved forms of caspases and PARP. β-Actin (actin) was used as a loading control,
and the levels of cleaved caspase-3, which were determined by densitometry, are provided at the bottom (S.D.o10% average in each case). (c) At 6 h after treatment with 30 μM
PGA1 or DMSO, wt MEFs were analyzed for apoptosis using annexin V/FITC staining in a FACS flow cytometer and the percentage of apoptosis was determined. (d) Wt MEFs
stimulated with 30 μM PGA1 or DMSO in the presence or absence of 20 μM Z-Asp-CH2-DCB were harvested 3 h after treatment. (Upper panel) Cell lysates were prepared and
analyzed as in (b). The levels of cleaved caspase-3, determined by densitometry, are provided at the bottom (S.D.o10% average in each case). (Lower panel) Annexin V/FITC
staining analysis was performed as in (c) and quantitative analysis of the percentage of the early apoptotic cells. Results are expressed as mean± S.D. (n= 4), ***P≤ 0.001 and
**P≤ 0.01. All experiments (c and d) were carried out four times with similar results
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transfected with H-Ras targeted either to the plasma
membrane or to endomembrane compartments. We found
that M1-H-Ras-SS and, to a lesser extent, KDEL-H-Ras-SS,
H-Ras constructs targeted to the ER and the Golgi apparatus,
respectively,21 were activated after stimulation by PGA1
(Figure 4a). In contrast, LCK-H-Ras-SS and CD8-H-Ras-
SS, which directed H-Ras specifically towards the plasma
membrane (lipid rafts and bulk membrane, respectively21)
were not activated by PGA1. Moreover, as shown in Figure 4b
(and Supplementary Figure S3A), activated caspase-3 and
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cell death was detected in double-knockout MEFs transfected
with ER-targeted form M1-H-Ras-SS.
To confirm that PGA1 preferentially activated Ras on
endomembranes, we studied the subcellular localization of
PGA1-induced Ras activation in vivo using double fluores-
cence confocal microscopy analysis of CH7C17 Jurkat cells, a
human T-cell line that does not express H-Ras, but activates
endogenous N-Ras and ERK in response to PGA1 or CD3
and apoptosis in response to PGA1 (Supplementary Figures
S3B–D). For this purpose, we co-transfected CH7C17 cells
with enhanced cyan fluorescent protein (CFP)-H-Ras, which
distributes between the plasma membrane and the ER/Golgi
complex, and YFP-RBD-Raf-1, a yellow fluorescent tracker of
H-Ras activation in live cells. Whereas YFP-RBD-Raf-1 was
localized throughout the cytoplasm of non-stimulated cells,
stimulation with CD3 or PGA1 increased colocalization of YFP-
RBD-Raf-1 with CFP-H-Ras on endomembranes (Figure 4c)
and was higher than on the plasma membrane (Figure 4d).
Thus, these results strongly suggest that PGA1 activates Ras
proteins in endomembrane compartments.
PGA1 induces calpain activation in fibroblasts. Caspase-
12 has been localized on the cytoplasmic side of the ER,
and is activated by alterations of the ER homeostasis such as
mobilization of intracellular calcium. As caspase-12 is
activated in response to PGA1 stimulation and the activation
of caspase-12 may occur through ER stress-induced
calpains,22 we tested the possible involvement of these
endopeptidases on the PGA1-induced apoptosis. Figure 5a
shows a weak but sustained increase of intracellular calcium
concentration upon PGA1 treatment in wt MEFs; in contrast,
the calcium levels displayed in H-Ras− /−/N-Ras− /− double-
knockout MEF cells were not significantly elevated. Western
blotting analysis of PGA1-treated wt MEFs revealed that
the levels of autoproteolytically cleaved calpain-1 were
much greater than in H-Ras− /−/N-Ras− /−double-knockout
MEFs, whereas the levels of calpain-2 remained unaltered
(Figure 5b). Furthermore, ALLN ((2S)-2-acetamido-4-methyl-
N-((2S)-4-methyl-1-oxo-1-(((2S)-1-oxohexan-2-yl)amino)pen-
tan-2-yl)pentanamide), a calpain specific inhibitor, completely
blocked the calpain activity induced by PGA1 in wt
MEFs (Figure 5c) and totally inhibited the proteolysis of
both caspase-12 and calpain-1 and, in a lower extent, the
activation of caspase-9 and -3 (Figure 5d). Taken together,
these data indicate that calpain activity is required for
cleavage of caspase-12 induced by PGA1.
ERK activation is required for PGA1-dependent apopto-
sis. One of the most important signaling pathways down-
stream of Ras is the RAF-MEK-ERK cascade, and previous
work has demonstrated that calpain is activated by ERK
signaling.23 As PGA1 induced both activation of Ras and
calpain proteins, we assessed the activation of these kinases
downstream of Ras. Treatment of wt MEFs with PGA1
induced activation of RAF, MEK, and ERK, although to a
lesser extent than FGF (Figure 6a). Consistent with these
results, PGA1 treatment promoted significant activation of an
Elk-1 luciferase reporter, although this activation was once
again weaker than that induced by FGF (Figure 6b). Despite
the weak and short duration of phospho-ERK levels (Supple-
mentary Figures S4A and B), we speculated that this
activation could be responsible for the apoptosis observed.
To examine whether ERK activation was required for PGA1-
induced apoptosis, the MEK1/2 inhibitor U0126 was added
before PGA1 treatment (~50 min) and left until the end of
PGA1 treatment. As shown in Figure 6c (and Supplementary
Figure S4C), in wt MEFs the inhibitor completely blocked
calpain-1 and caspase-12, -9 and -3 activation induced
by PGA1. Moreover, both the calpain activity and Annexin
V-positive cell number were markedly reduced in the
presence of the MEK inhibitor upon PGA1 stimulation
(Figures 6d and e). Taken together, these data strongly
suggest that PGA1 promotes apoptosis through the activation
of the RAF-MEK-ERK pathway.
PGA1 also induces apoptosis in human cancer cells.
Apoptosis is the leading mechanism proposed to account for
the antitumoral and antiproliferative effects of PGA1 in cancer
cells.24 Indeed, we assayed PGA1-induced apoptosis in a
panel of 14 human cell lines from different cancer types
(Supplementary Figures S5A and S6). Although the sensi-
tivity to PGA1 showed differences between the distinct cancer
cell lines, it remained very similar among lines of the same
tumor type, with the exception of the non-small-cell lung
cancer (NSCLC) lines. Thus, in this case, most H358 and
H23 cells underwent apoptosis upon PGA1 treatment,
whereas A549, H522, and H2126 cells showed higher resis-
tance to PGA1-induced cell death. Next, we examined
whether PGA1 treatment activated in human cancer cells
the same mechanism than in MEFs. Western blotting and
analysis of apoptotic markers in H358 and A549, K-RasV12-
mutated NSCLC lines with different sensitivity to PGA
(Figure 7a), showed activation of calpain-1, caspase-9, and
Figure 2 Apoptosis induced by PGA1 depends of H-Ras and N-Ras. Serum-starved wt, H-Ras
− /−, N-Ras− /−, or H-Ras− /−/N-Ras− /− MEFs were treated as in Figure 1b.
(a, upper panel) A representative analysis as in Figure 1b. (Lower panel) Annexin V/FITC analysis was performed as in Figure 1c. Results (mean± S.D., n= 4) are expressed as
fold increase in the percentage of DMSO-treated cells ***P≤ 0.001, NS, nonsignificant. (b) H-Ras− /−/N-Ras− /− MEFs transiently transfected with pCEFL-KZ-AU5-H-Ras-wt
(AU5-H-Ras), pCEFL-KZ-AU5-N-Ras-wt (AU5-N-Ras), or pCEFL-KZ-AU5 (Vector) were treated as in (a). Wild-type MEFs (WT) were analyzed in parallel using the same stimuli.
Expression level of the ectopic AU5-Ras was assessed using anti-AU5. Levels of cleaved PARP (determined by densitometry) are provided at the bottom of the panel. (c) NIH3T3
cells stably transfected with pCEFL-KZ-AU5-H-Ras-wt (AU5-H-Ras), pCEFL-KZ-AU5-N-Ras-wt (AU5-N-Ras), or pCEFL-KZ-AU5 (Vector) were serum starved for 24 h and then
incubated with vehicle (− ) or PGA1 (10 and 30 μM) and harvested 3 h after treatment. (Upper panel) Cell lysates were analyzed as in (b). (Lower panel) Annexin V/FITC staining
analysis was performed as above (using 30 μM of PGA1). Results (mean± S.D., n= 3) are expressed as fold increase in the percentage of DMSO-treated cells. ***P≤0.001 and
*P≤ 0.05 versus non-stimulated (DMSO) cells. (d) NIH3T3 cells transiently transfected with pCEFL-KZ-AU5-H-Ras-N17 (H-Ras-N17) or pCEFL-KZ-AU5 (Vector) were serum
starved for 24 h and then incubated with vehicle (− ) or 30μM PGA1 (+). Cell lysates were obtained 3 h after treatment and analyzed as in (c). The levels of cleaved caspase-3
(a–d), which were determined by densitometry, are provided at the bottom of each panel. The figures indicate the average levels of cleaved caspase-3 relative to controls of at
least four independent experiments (S.D.o10% average in each case)
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caspase-3 in H358 cells but not in A549 cells. Altogether,
these data suggest that in human cancer cells the
mechanism of PGA1-induced apoptosis may be mediated
by a similar set of signaling proteins than in mouse embryo
fibroblast cells.
Discussion
Although PGA1 displays potent antiproliferative activity, a
fundamental yet unanswered question is the underlined
mechanism. The cyclopentane ring of CyPG posseses an
α-, β-unsaturated carbonyl group that reacts with sulfhydryl
groups in cysteine residues of cellular proteins by means of
Michael’s addition.25 During recent years, several protein
targets have been identified for CyPG, including NF-κB, AP1,
Keap-1, and LKB1.26–28 We have reported that Ras proteins
can also bemodified by the addition of 15d-PGJ2 and PGA1; in
fact, the three Ras isoforms (H-Ras, N-Ras, and K-Ras4B)
bind to and are activated byPGA1.
14,20 Induction of apoptosis by
PGA1 occurs in different cell types, such as in endothelial
cells, gastric epithelial cells, lung, prostate, and colon cancer
cells.16,17,29 In contrast, some cellular models suggest that
PGA1 protects against apoptosis through a mechanism
that involves inhibition of NF-κB activation.30 Our results show
that PGA1 induces apoptosis by a caspase-dependent
mechanism that requires either H-Ras or N-Ras, but not
K-Ras. PGA1-induced apoptosis is likely initiated by an ER/
Golgi complex pool of Ras and requires activation of ERK.
Indeed, the only MEFs that showed activation of caspase-3
after stimulation with PGA1 were those that harbor the H-ras
and/or the N-ras genes. Consistent with this observation, the
ectopic overexpression of H-Ras or N-Ras in double-knockout
MEFs was sufficient to rescue the apoptotic levels induced by
PGA1. Moreover, NIH3T3 cells constitutively overexpressing
ectopic H-Ras or N-Ras displayed synergistic enhancement of
PGA1 apoptotic effects, even at low concentrations. In
addition, overexpression of a dominant-negative mutant of
H-Ras (H-Ras-N17) in fibroblasts caused a significant reduc-
tion in caspase-3 activation, indicating that functional Ras
signaling is essential for PGA1-induced apoptosis.
In this study, we have provided evidence that the PGA1
activates Ras proteins in the ER and in the Golgi complex, but
not at the plasma membrane (lipid rafts or bulk membrane).
CFP-H-Ras in CH7C17 cells colocalized in vivo with YFP-
RBD-Raf-1 in endomembrane systems upon stimulation with
PGA1. A large body of evidence supports the possibility that
H-Ras/N-Ras activation can occur in these organelles; never-
theless, the specific outcome of this activation remains
debated. Thus, activated H-Ras targeting the Golgi apparatus
has been reported to elicit strong activation of ERK and AKT,
but weak activation of JNK, whereas the opposite effects were
described when H-Ras targeted the ER.31 Other studies,32
however, which used the Golgi apparatus-tethering signal
KDELr containing the mutation N193D that fixes it perma-
nently to the Golgi apparatus, reported that activated H-Ras
tethered to the Golgi apparatus (KDEL-H-RasV12-SS) only
Figure 3 Ras-Cys118 is necessary for PGA1-induced apoptosis. H-Ras
− /−/N-Ras− /−MEFs transiently transfected with pCEFL-KZ-AU5 (Vector), pCEFL-KZ-AU5-H-Ras-wt
(WT), pCEFL-KZ-AU5-H-Ras-C118S (C118S), or pCEFL-KZ-AU5-H-Ras-C184S (C184S) were treated as in Figure 2b. (a) Cell lysates were as in Figure 2b. Levels of cleaved
caspase-3 are provided at the bottom (S.D.o10% average in each case, n= 4). (b) Annexin V/FITC staining analysis was performed as in Figure 2c (mean± S.D., n= 4).
***P≤0.001 versus non-stimulated (DMSO) cells
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induced Ral and JNK signaling, whereas hyperactive H-Ras
targeting the ER (M1-H-RasV12-SS) displayed a potent
activation of ERK and AKT. We observed that PGA1 induces
transitory and weak activation of ERK, although no effects on
AKT or JNK phosphorylation were observed. An unsolved
issue concerns the reason why Ras proteins resulted
specifically activated by PGA1 in the ER and Golgi. The ability
of PGA1 to stimulate transitory activation of ERK appears to
contradict most studies about apoptosis induced by the Ras-
RAF-MEK-ERK pathway, where in response to numerous
stress stimuli, ERK activation was strong and sustained,
whereas transient activation of ERK protects against death.33
Figure 4 Activation of Ras by PGA1 occurs in endomembrane compartments. (a) HeLa cells transiently transfected with pCEFL-KZ-AU5, pCEFL-KZ-HA-H-Ras-wt, pCEFL-
KZ-HA-M1-H-Ras-SS, pCEFL-KZ-HA-KDEL-H-Ras-SS, pCEFL-KZ-HA-LCK-H-Ras-SS, or pCEFL-KZ-HA-CD8-H-Ras-SS were serum starved for 24 h and then incubated with
DMSO, EGF (100 ng/ml, for 15 min) or PGA1 (30 μM for 15 min). Ras-GTP was recovered from cell lysates by binding to immobilized GST containing the Ras-GTP binding
domain of RAF and detected by immunoblotting with anti-HA monoclonal antibody (upper panel). The expression levels of the transfected HA-H-Ras were detected by
immunoblotting the cell extracts with the corresponding anti-HA monoclonal antibody (lower panel). Ras-GTP levels were determined by densitometry and are shown at the
bottom (S.D. o10% average in each case, n= 4). (b) H-Ras− /−/N-Ras− /− MEFs transiently transfected with pCEFL-KZ-HA-H-Ras-wt (WT), pCEFL-KZ-HA-M1-H-Ras-SS
(M1), or pCEFL-KZ-HA-KDEL-H-Ras-SS (KDEL) were treated and analyzed as in Figure 2b. Levels of cleaved caspase-3 are provided at the (S.D.o10% average in each case,
n= 3); black arrows show transfected Ras. (c) CH7C17 cells transiently co-transfected with pEYFP-Raf-RBD (yellow, RBD-Raf-1) and pECFP-H-Ras-wt (cyan, H-Ras-CFP) were
serum starved for 24 h and then incubated with DMSO (non-stimulated), 30 μM PGA1, or 5 μg/ml anti-CD3 Ab. The subcellular localization of RBD-Raf-1 and H-Ras was
recorded using confocal fluorescence microscopy at 15 min after treatment. Right, the corresponding profile analysis of the intensity and distribution of H-Ras (cyan solid line) and
RBD-Raf-1 (yellow dashed line) along a cross-section of the regions of interest R1–3 (ER/Golgi) are shown. (d) Quantitative analysis of the cellular localization of YFP-RBD-Raf-1
(RBD) in CH7C17 cells transiently co-transfected with pEYFP-Raf-RBD and pECFP-H-Ras-wt. Histograms show the ratio of YFP-RBD-Raf-1/CFP-H-Ras accumulation in the ER/
Golgi complex (white) or at the plasma membrane (PM) (green) of CH7C17 cells. At least 100 cells were scored for each condition. Data are expressed as mean± S.D. (n= 3).
***P≤ 0.001 and *P≤ 0.05 versus non-stimulated (DMSO) cells (− )
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However, overexpression of the hyperactive M1-H-RasV12-
SS that promotes constitutive ERK activation and generates
an antiapoptotic signal32 did not induce apoptosis in wt MEFs
(Supplementary Figure S4D).
Further studies are necessary to elucidate the transduction
pathway downstream of ERK that is associated with
caspase-3 cleavage upon stimulation with PGA1. Never-
theless, it has been reported that growth factors activate
calpains downstream of ERK.34 Our results further support a
link between PGA1, ERK, and calpain activation, as the MEK
inhibitor U0126 abolished ERK, calpain, and caspase activa-
tion and therefore PGA1-induced apoptosis, suggesting that
calpains have an essential role in the apoptotic pathway
induced by PGA1 downstream of ERK activation. Although
activation of caspase-12, a marker of ER stress, may occur
through ER stress-induced calpains,35 we do not know if the
Ras activation induced by PGA1 in endomembranes could
trigger an ER stress response. CyPGs exert a variety of
biological actions, most remarkably among them the stress
response. PGA1 is an important inducer of stress response by
increasing the synthesis of HSPs and activating heat-shock
transcription factors.36 In rats with acute liver damage,
pretreatment with PGE1 and somatostatin inhibits apoptosis
and alleviates ER stress by induction of HSP70 and BiP/
GRP78 (immunoglobulin-binding protein/), but suppression of
CHOP (C/EBP homologous protein).37 Indeed, Δ12-PGJ2 and
PGA1 induce BiP gene expression through unfolded protein
response (UPR).38 BiP is a molecular chaperone that is
synthesized constitutively, although accumulation of unfolded
proteins in the ER changes in Ca2+ levels, reducing environ-
ment and block of glycosylation induces transcription of the
BiP gene.39 Furthermore, ER stress can be induced by a
Figure 5 PGA1 induces calpain activation. Serum-starved wt or H-Ras
− /−/N-Ras− /− MEFs were stimulated with 30 μM PGA1 or DMSO. (a) Increase in cytosolic Ca
2+
levels. Measurements are given in relative fluorescent units (RFU) during 30 min. Data are expressed as mean± S.D. of three independent experiments. (b) Cell lysates were
obtained 3 h after treatment and analyzed for detection of calpain-1, calpain-2, and actin. (c) Calpain activity was measured 3 h after treatment. Measurements are given in RFUs.
Data are expressed as mean±S.D. (n= 3). ***P≤0.001 versus control and **P≤ 0.01. (d) Serum-starved wt MEFs were stimulated with 30 μM PGA1 or DMSO in the presence
of the calpain inhibitor ALLN (10 μM). Cell lysates were obtained 3 h after treatment and analyzed as in Figure 2b and in (b). Levels of cleaved calpain-1 and caspase-3 are
denoted at the bottom of each panel (S.D.o10% average in each case, n= 3)
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variety of cellular functions, including a wide spectrum of Ras
targets. Thus, in primary human melanocytes H-RasV12-
induced senescence was mediated by the UPR, initiated by
the PI(3)K/AKT pathway, while in mouse fibroblasts or in
established or immortalized cells, the UPR drive to cell cycle
arrest.40,41 Oncogenic H-Ras downregulates CHOP expres-
sion and is required for transformation while the expression of
exogenous CHOP blocks transformation in NIH3T3 cells.42
Recent studies have demonstrated that the activation of
K-Ras on the ER surface cooperates with Nox4 to initiate the
UPR and autophagy and therefore prevent cell death and
promote differentiation in HUVEC cells.43 We found evidences
supporting the existence of a PGA1-induced UPR. Indeed,
upon prostaglandin stimulation, we observed an elevation in
the levels of the proteins BiP and CHOP in wt MEFs and H358
cells (Supplementary Figures S5B and S5C). These data
Figure 6 ERK activation is necessary for PGA1-dependent apoptosis. Serum- starved wt MEFs were stimulated with 30 μM PGA1, FGF, or DMSO. (a) Lysates prepared from
cells 15 min after treatment underwent western blotting for relevant components of the RAF-MEK-ERK pathway. Levels of p-c-RAF, p-MEK1/2, and p-ERK1/2 are provided at the
bottom of each panel (S.D.o10% average in each case, n= 4). (b) Cells were co-transfected with the plasmids pcDNAIII-Gal4-Elk-1, pGal4-Luc, and pTK-Renilla 24 h before
synchronization. Firefly luciferase activity was determined 6 h after stimulation with PGA1 and normalized to Renilla luciferase activity. Results, in arbitrary units (AU), are
expressed as mean± S.D. (n= 3). ***P≤ 0.001 versus control. (c) MEK1/2 inhibitor U0126 (5 μM) was added ~ 50 min before PGA1 treatment (30 μM) and left in the medium
until processing. Cell lysates were prepared and analyzed as in Figure 5c. Levels of cleaved calpain-1, cleaved caspase-12, cleaved caspase-9 and caspase-3 are indicated at
the bottom of each panel (S.D.o10% average in each case, n= 3). (d) Calpain activity was measured as in Figure 5d. Data are expressed as mean± S.D. (n= 3). ***P≤ 0.001
versus control and **P≤ 0.01. (e) Annexin V/FITC staining analysis was performed as in Figure 1c. Results are expressed mean±S.D. (n= 4). ***P≤ 0.001 and **P≤ 0.01
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strongly suggest that PGA1 could trigger an ER stress
response through H- and N-Ras activation. In summary, our
study provides new insights into the molecular mechanism
underlying the induction of apoptosis by PGA1. Our findings
reveal a novel mechanism by which PGA1 stimulates cell
death as a consequence of specific activation of H-Ras and
N-Ras in endomembranes (ER and the Golgi complex),
whereas K-Ras was dispensable for this function (summar-
ized in Figure 7b). These data also have implications for signal
transduction and cancer, as the RAF-MEK-ERK cascade is
the signaling pathway responsible for this cell death through
ERK-induced calpain activity and subsequent caspase
activation even in cells with deletion of the TP53 gene and
that harbor oncogenic K-Ras as H358 cells. Our results
highlight the relevance for physiological outcomes of the
intensity, duration, and specific subcellular location of Ras
activation. PGA1 and some analogs received great attention in
the 1990 s; although some analogs showed promising results
in preclinical studies, their use in the clinical practice has not
been put forward.24 More recently, other potential clinical uses
of PGA1 or its analogs have been explored, including the
potential beneficial effects of A-type cyclopentenone prosta-
glandins in atherosclerosis44 and its potential use in the
inhibition of the aldo-keto reductase enzymes, which are
involved in cancer resistance to chemical treatment and in the
development of diabetic complications.45,46 Here our data
highlight the possibility that cyclopentenone prostaglandins,
because of their specific cellular effects, can be useful in the
design of new therapeutic drugs and these studies are
under way.
Materials and Methods
Materials. Cell culture medium was purchased from Invitrogen (Carlsbad, CA,
USA). The pancaspase inhibitors Z-Asp-CH2-DCB (Z-Asp-2,6-dichlorobenzoylox-
ymethylketone), U0126, and GW5074 were from Biomol Research Laboratories Inc.
(Plymouth Meeting, PA, USA). PGA1, propidium iodide, DAPI, and recombinant
bFGF were from Sigma-Aldrich (St. Louis, MO, USA). DEA-NO was from Alexis
Biochemicals (Carlsbad, CA, USA).
Cell culture. HeLa, SH-SY5Y, U373, TPC1, A2780, SCC12, A431, SW480
(ADH-V and S: normal or overexpressing Spry2),47 HT29, A549, H522, H2126,
H358, H23, and NIH3T3 cells were obtained from American Type Culture Collection
(ATCC, Manassas, VA, USA) and cultured in DMEM or RPMI medium
supplemented with 10% FBS (Invitrogen), penicillin (100 U/ml), streptomycin
(100 μg/ml), and L-glutamine (2 mM) at 37 °C in a humidified 5% CO2 atmosphere.
Knockout MEFs for H-ras and/or N-ras genes are described elsewhere.48 CH7C17
cells were cultured in RPMI medium supplemented with 10% FBS (Invitrogen). The
synchronization process involved cells being cultured in normal medium for 24 h,
serum starved for 24 h, and then treated with PGA1 in the absence of serum.
Human cell lines were authenticated by the Genomics Service of Instituto de
Investigaciones Biomédicas Alberto Sols (Madrid, Spain) using the GenePrint 10
System (Promega), which allows coamplification and three-color detection of 10
human loci: TH01, TPOX, vWA, amelogenin, CSF1PO, D16S539, D7S820,
D13S317, D21S11, and D5S818. These loci collectively provide a genetic profile
with a random match probability of 1 in 2.92 × 109 and are used for human cell line
and tissue authentication and identification and human cell line cross-contamination
determination. STR profiles are sent for comparison against cell line databases
such as ATCC and DSMZ (Deutsche Sammlung von Mikrorganismen and
Zellkulturen). Cells were tested routinely to ensure there was no mycoplasma
contamination (Universal Mycoplasma Detection Kit; ATCC, Manassas, VA, USA;
no. 30-1012).
Cell proliferation and cell cycle analysis. Cells (2.5 × 105) were seeded
in triplicate in 60 mm dishes and synchronized as described above. They were then
treated with FGF, PGA1, or vehicle (dimethyl sulfoxide (DMSO)) for the specified
times, trypsinized at different intervals, and counted with a hemocytometer. Images
were collected with a DS-L1 Digital Sight Camera System (Nikon, Nikon Instruments
Europe B.V., L´Hospitalet de Llobregat, Spain) coupled to a Eclipse TS100 inverted
microscope, × 40 objective lens (Nikon). Cell cycle profiles were determined by
propidium iodide staining (0.1 mg/ml) and flow cytometry.
Annexin V-FITC staining. Cell lines were grown and treated as described
above. Apoptosis was determined using fluorescein isothiocyanate-conjugated
Annexin V (Annexin V-FITC)/Propidium Iodide Apoptosis Detection Kit (R&D
systems, Minneapolis, MN, USA) according to the manufacturer’s instructions. Cells
that were positive for Annexin V-FITC and/or propidium iodide were analyzed using
a BD FACS flow cytometer (SpainCustomer Service, San Agustin de Guadalix,
Spain).
Apoptosis assays. Cells were trypsinized, mounted on glass slides, and then
fixed with 70% ethanol. Morphological changes in chromatin structure were
assessed after staining with DAPI. Apoptosis was characterized according to
chromatin condensation and fragmentation using fluorescence microscopy. The
incidence of apoptosis in each preparation was analyzed by counting 500 cells and
determining the percentage of apoptotic cells. Images were collected with an HCX
PL APO × 40 NA 1.32 oil-immersion objective lens (Leica, Leica Microsistemas
S.L.U., Barcelona, Spain).
DNA constructs. The plasmids used pCEFL-KZ-AU5, pCEFL-KZ-AU5-H-Ras-
wt, pCEFL-KZ-HA-H-Ras-wt, pCEFL-KZ-AU5-N-Ras-wt, and pGEX-GST-Raf-RBD
have been described elsewhere,14,49–52 as have pCEFL-KZ-AU5-H-Ras-C118S
(H-Ras-C118S), pCEFL-KZ-AU5-H-Ras-C184S pCEFL-KZ-HA-M1-H-Ras-SS, pCEFL-
KZ-HA-KDEL-H-Ras-SS, pCEFL-KZ-HA-CD8-H-Ras-SS, pCEFL-KZ-HA-LCK-H-Ras-
SS, pCEFL-KZ-HA-M1-H-RasV12-SS, and pCEFL-KZ-HA-KDEL-H-RasV12-SS21,32
and pEYFP-Raf-RBD and pECFP-H-Ras-wt.53
Cell transfection studies. Transient transfection was performed in NIH3T3,
HeLa, and MEFs using Jet-PeiTM (Polyplus-Transfection, Illkirch, France). CH7C17
cells (15 × 106) were transfected using the Pulser X-cell Electroporation System
Figure 7 PGA1 induces cell death in cancer cells. (a) H358 and A549 cells were
treated and analyzed in Figure 2a. Levels of cleaved caspase-3 are at the bottom
(S.D. o10% average in each case, n= 3). (b) A model illustrating the signaling
cascades initiated by H-Ras and N- Ras activation after PGA1 and their roles in
apoptosis
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(Bio-Rad, Hercules, CA, USA) at 250 V and 1200 μF, with 25 μg of expression
plasmids encoding the indicated constructs.
Reporter gene analysis. Cells were transfected with 16 ng of pCDNAIII-
Gal4-Elk-1, 0.1 μg of pRL-TK (a plasmid containing the Renilla luciferase gene
under control of the HSV-TK promoter), and 0.3 μg of the reporter plasmid pGal4-
Luc (containing the Photinus luciferase gene controlled by six copies of a Gal4-
responsive element).
T-cell activation and confocal microscopy. CH7C17 cells (15 × 106) were
allowed to settle in LabTek II chambers (Nalge Nunc International, Sigma-Aldrich
Quimica SL, Madrid, Spain) and maintained at 37 °C in a 5% CO2 atmosphere in
phenol red-free RPMI medium 1640 containing 25 mM HEPES and 2% FBS in an
incubator coupled to a Leica TCS SP2 confocal microscope (Leica Microsistemas
S.L.U.). T cells transiently co-transfected with YFP-RBD-Raf-1 and CFP-H-Ras were
serum starved at 37 °C for 2 h before stimulation with DMSO, PGA1 (30 μM/15 min),
or anti-human CD3ε T3b mAb (5 μg/ml). Time-lapse confocal images were collected
with an HCX PL APO × 40 NA 1.32 oil-immersion objective lens (Leica), and
fluorescence images were captured every 1 min. Six confocal Z-sections were
necessary to capture the entire fluorescent signal at each time. The ratio of
fluorescence intensity between the cellular regions of interest was calculated in a single
Z plane, corresponding with the maximum fluorescence plane, by using Leica Confocal
Software, version 2.61 (Leica Microsystems, Leica Microsistemas S.L.U.). At least 100
cells were analyzed for each sample. For fluorescence profile analysis, 8 μm cross-
sections were drawn (white bar).
Western blot analysis. Cells were lysed in a buffer containing HEPES
25 mM, pH 7.5, 150 mM NaCl, 1% NP40, 10% glycerol, 0.1% SDS, 1% sodium
deoxycholate, 10 mM MgCl2, 2 mM EDTA and Protease Inhibitor Cocktail from
Sigma-Aldrich (catalog number P8340). Cell extracts (20 μg protein per lane)
underwent SDS-PAGE before being transferred to PVDF membranes (Millipore,
Bedford, MA, USA). After blocking with 5% milk in 0.1% Tween-20/PBS, membranes
were incubated with the primary antibody. The primary antibodies used at 1 : 1000
dilution were caspase-3 (8G10) (Cell Signaling Technology (CST), Boston, MA,
USA; catalog number 9665), caspase-9 (CST; catalog number 9508), caspase-12
(CST; catalog number v2202), caspase-8 (CST; catalog number 4927), PARP
(CST; catalog number 9542), p-c-Raf (Ser 338) (CST; catalog number 9427), MEK
(CST; catalog number 9122), p-MEK (Ser217/221)(CST; catalog number 9121),
ERK (CST; catalog number 4696), p-ERK (thr202/tyr204) (CST; catalog number
9101), calpain-1 (CST; catalog number 2556), calpain-2 (CST; catalog number
2539), BiP (CST; catalog number 3138), and CHOP (CST; catalog number 2895),
K-Ras (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA; catalog number
sc-30), N-Ras (sc-31), and CD3ε T3 mAb have been previously described.49 Actin
(sc-47778), H-Ras (Y132) (Abcam, Cambridge, UK; catalog number ab32417),
c-Raf (BD Transduction Laboratories; San Jose, CA, USA), HA (MMS-101R), and
AU5 (MMS-135R) monoclonal antibodies (Berkeley Antibody Company, Berkeley,
CA, USA), and anti-rabbit and anti-mouse (Li-Cor Biosciences, Lincoln, NE, USA).
Anti-mouse or anti-rabbit horseradish peroxidase (1 : 3000; Bio-Rad) was used as a
secondary antibody. Bands were visualized using an Enhanced Chemiluminescence
Detection Kit (Amersham, Arlington Heights, IL, USA).
Ras-GTP detection. Ras-GTP levels were estimated by pull-down assays.14
DNA laddering. Floating and adherent cells were collected in TE/Triton buffer
(0.2% Triton X-100, 10 mM Tris-HCl, pH 8.0, and 1 mM EDTA). Following incubation
on ice for 10 min, an aliquot of the lysate containing total DNA was removed, and the
remaining lysates were centrifuged for 15 min at 14 000 × g and 4 °C. Supernatant
containing low-molecular-weight DNA was transferred to a fresh tube and treated with
DNase-free RNase A (60 μg/ml) for 1 h at 37 °C. SDS (0.5%) and proteinase K
(150 μg/ml) were added, and the samples were incubated for 1 h at 50 °C. DNA was
precipitated by the addition of 0.1 volumes of 0.5 M NaCl and 1.0 volume of
isopropanol, followed by incubation on ice for 10 min. After centrifugation, DNA in TE
buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA) was analyzed on 2% agarose gels.
Intracellular calcium measurement. Measurement of intracellular cal-
cium ions was determined by the Fluo-4 Direct Calcium Assay Kit (Invitrogen,
Molecular Probes, Life Technologies S.A., Alcobendas, Spain) according to the
manufacturer's instructions. Excitation at 494 nm and emission at 516 nm.
Calpain activity determination. Detection of calpain activity was performed
as described previously.54
Statistical analysis. Data were analyzed using the SPSS software (SPSS
Inc., Chicago, IL, USA). ANOVA was used to test statistical significance. Results are
expressed as mean± S.D. of the indicated number of experiments. Statistical
significance was evaluated using the t-test for unpaired observations. Western blots
were analyzed using linear correlations between increasing amounts of protein and
signal intensity.
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